# RWO-06B Subjectivesv2 Live-Readiness Identity

RUN_ID: `20260424T080121Z`

## Result

`RWO06B_SUBJECTIVESV2_LIVE_READINESS_IDENTITY_PREPARED_NO_LIVE`

The active handoff `subjectivesv2-diseasev3-live-payload-identity-and-approval-not-created` is completed for exactly one endpoint: `subjectivesv2`.

No live SOAP Trial mutation was executed.

## Endpoint Selection

`subjectivesv2` was selected before `diseasev3` because it is the smaller first mutation scope:

- current product SOAP save path is local-only `/api/local/charts/subjectives`;
- the fixed official server route now exists at `/api/orca/official/chart-support/subjectives-mod-v2`;
- the payload is a dummy outpatient create payload for Trial target `00001`;
- it avoids the disease list create/update/delete ambiguity, disease 3-layer boundary, and diagnosis persistence semantics that make `diseasev3` higher risk.

`diseasev3` remains blocked for a separate endpoint identity and business-scope record.

## Subjectivesv2 Identity

| Field | Value |
|---|---|
| Workflow | `subjectivesv2` |
| Workflow ID | `rwo06b-subjectivesv2-live-readiness-v1` |
| Official server route | `POST /api/orca/official/chart-support/subjectives-mod-v2` |
| ORCA endpoint | `/orca25/subjectivesv2` |
| Request scope | outpatient SOAP subjective create, class `01`, Request_Number `01` equivalent only |
| Target | Trial dummy target `00001` only |
| Payload | `web-client/qa/payloads/phase4/subjectivesv2_phase4_dummy_native_intent_v1.json` |
| Payload SHA-256 | `9c90a3b0d731bce2b9e1280d01a5c61222bbd97126e3f9fc50aa6135842dc308` |
| Duplicate-live checkpoint key | `rwo06b:subjectivesv2:rwo06b-subjectivesv2-live-readiness-v1:target-00001:operation-create:request-01:class-01:payload-sha256-9c90a3b0d731bce2b9e1280d01a5c61222bbd97126e3f9fc50aa6135842dc308` |

## Business-Success Criteria

Future live execution for this exact identity may only be classified as success when all endpoint-specific parsed conditions are true:

- transport status is 2xx;
- `Api_Result` is zero-equivalent;
- endpoint response root is the expected `subjectivesmodres`;
- completion evidence is present, not inferred from HTTP 200 or wrapper exit 0;
- no raw ORCA body, raw SOAP text, raw patient/insurance detail, credential, HAR, trace, video, screenshot, or raw network artifact is captured.

The checked-in stub remains `notVerified` because completion evidence is absent.

## Misuse Cases Checked

| Misuse case | Control |
|---|---|
| Live SOAP mutation is accidentally enabled by the identity record | Wrapper evidence keeps `liveMutationPermittedByThisPrompt=false` and `liveTrialAction=not_run_forbidden_by_contract`. |
| HTTP 200 or zero `Api_Result` is promoted to success | Parser/test requires completion evidence; stub classification remains `notVerified`. |
| Disease readiness is implied by SOAP readiness | Claim boundary and handoff keep `diseasev3` blocked behind a separate identity and scope record. |

## Verification

| Check | Result |
|---|---|
| `node --check web-client/scripts/qa-lib/phase4-soap-disease-safe-evidence.mjs && node --check web-client/scripts/qa-phase4-safe-soap-disease.mjs` | pass |
| `npm run test -- scripts/__tests__/phase4SoapDiseaseSafeEvidence.test.ts` | pass / 1 file / 9 tests |
| `RUN_ID=20260424T080121Z node web-client/scripts/qa-phase4-safe-soap-disease.mjs --dry-run ... --workflow subjectivesv2 ...` | pass / no live ORCA / response `notVerified` |

## Evidence

- [summary.sanitized.json](summary.sanitized.json)
- [wrapper-output/phase4-soap-disease-summary.sanitized.json](wrapper-output/phase4-soap-disease-summary.sanitized.json)
- [command-log.jsonl](command-log.jsonl)

## Claim Boundary

This work does not claim SOAP `subjectivesv2` Trial reachability, `diseasev3` Trial reachability, disease update/delete readiness, Request_Number `02` / `03` / `04`, fullflow, production ORCA readiness, S3/object-storage readiness, broad clinical release readiness, or final release GO.

Credentials captured: `false`

Raw artifacts captured: `false`

## Next Step

Create the separate `diseasev3` no-live live-readiness identity and approval/business-scope record before any disease Trial mutation. Keep live `subjectivesv2` execution blocked until a future prompt explicitly authorizes this exact duplicate-live checkpoint and runtime readiness is rechecked.
